参考文献/References:
[1] Yuan L, Dai X, Fu H, et al. Vaspin protects rats against myocardial ischemia/reperfusion injury(MIRI) through the TLR4/NF-kappaB signaling pathway[J]. Eur J Pharmacol, 2018, 835: 132-139.
[2] Guo X, Jiang H, Yang J, et al. Radioprotective 105 kDa protein attenuates ischemia/reperfusion-induced myocardial apoptosis and autophagy by inhibiting the activation of the TLR4/NF-κB signaling pathway in rats[J]. Int J Mol Med, 2016, 38(3): 885-893.
[3] Li M, Liu J, Bi Y, et al. Potential medications or compounds acting on toll-like receptors in cerebral ischemia[J]. Curr Neuropharmacol ,2017, 16(2): 160-175.
[4] Wang PF, Xiong XY, Chen J, et al. Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment[J]. J Neuroinflammation, 2015, 12(1): 80.
[5] Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy[J]. Nat Rev Nephrol, 2016, 12(1): 13-26.
[6] Cui J, Chen Y, Wang HY, et al. Mechanisms and pathways of innate immune activation and regulation in health and cancer[J]. Hum Vaccin Immunother, 2014, 10(11): 3270-3285.
[7] Selejan S, Poss J, Walter F, et al. Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock[J]. Eur Heart J, 2012, 33(9): 1085-1094.
[8] Fatih A, Smeets MB, O’Neill LAJ, et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody[J]. Circulation, 2010, 121(1): 80-90.
[9] Han Y, Liao X, Gao Z, et al. Cardiac troponin I exacerbates myocardial ischaemia/reperfusion injury by inducing the adhesion of monocytes to vascular endothelial cells via a TLR4/NF-κB-dependent pathway[J]. Clin Sci (Lond), 2016, 130(24): 2279-2293.
[10] Dong LY, Chen F, Xu M, et al. Quercetin attenuates myocardial ischemia-reperfusion injury via downregulation of the HMGB1-TLR4-NF-κB signaling pathway[J]. Am J Transl Res, 2018, 10(5): 1273-1283.
[11] Chen H, Zhang RQ, Wei XG, et al. Mechanism of TLR-4/NF-κB pathway in myocardial ischemia reperfusion injury of mouse[J]. Asian Pac J Trop Med, 2016, 9(5): 503-507.
[12] Chen C, Feng Y, Zou L, et al. Role of Extracellular RNA and TLR3-Trif Signaling in Myocardial Ischemia-Reperfusion Injury[J]. J Am Heart Assoc, 2014, 3(1): e000683.
[13] Li W, Hsiao HM, Higashikubo R, et al. Heart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling[J]. JCI Insight, 2016, 1(12) : e87315.
[14] Mersmann J, Berkels R, Zacharowski P, et al. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury[J]. Crit Care Med, 2010, 38(3): 903-909.
[15] Ha T, Hu Y, Liu L, et al. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism[J]. Cardiovasc Res, 2010, 87(4): 694-703.
[16] Arslan F, Houtgraaf JH, Keogh B, et al. Treatment with OPN-305, a humanized anti-toll-like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs[J]. Circ Cardiovasc Interv, 2012, 5(2): 279-287.
[17] Tang Y, Zhou G, Yao L, et al. Protective effect of Ginkgo biloba leaves extract, EGb761, on myocardium injury in ischemia reperfusion rats via regulation of TLR-4/NF-κB signaling pathway[J]. Oncotarget, 2017, 8(49): 86671-86680.
[18] Yang YF, Peng K, Liu H, et al. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway[J]. Clin Exp Pharmacol Physiol, 2017, 44(3): 353-361.
[19] Feng Y, Chen H, Cai J, et al. Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via Toll-like receptor 7 signaling[J]. J Biol Chem, 2015, 290(44): 26688-26698.
[20] Zhou DC, Su YH, Jiang FQ, et al. CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis[J]. J Cell Physiol, 2018, 233(5): 4245-4257.
[21] Pilz PM, Hamza O, Gidl?f O, et al. Remote ischemic perconditioning attenuates adverse cardiac remodeling and preserves left ventricular function in a rat model of reperfused myocardial infarction[J]. Int J Cardiol, 2019, 285: 72-79.
[22] Zhang DW, Zhang L, Liu JG, et al. Mechanisms of Chinese herbs combined with ischemic postconditioning in protecting myocardium of rats from ischemia-reperfusion injury[J]. Zhong Xi Yi Jie He Xue Bao, 2010, 8(5): 465-471.
[23] Zhang J, Zhang J, Yu P, et al. Remote ischaemic preconditioning and sevoflurane postconditioning synergistically protect rats from myocardial injury induced by ischemia and reperfusion partly via inhibition TLR4/MyD88/NF-κB signaling pathway[J]. Cell Physiol Biochem, 2017, 41(1): 22-32.
[24] Kim SC, Wu S, Fang X, et al. Postconditioning with a CpG containing Oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model[J]. Life Sciences, 2014, 119(1-2): 1-8.
相似文献/References:
[1]张明 王敬萍.Nur77和GRP78与糖尿病心肌缺血再灌注损伤的关系研究[J].心血管病学进展,2020,(6):571.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.003]
ZHANG Ming Wang Jingping.Relationship between Nur77 and GRP78 and Myocardial Ischemia-reperfusion Injury in Diabetic Patients[J].Advances in Cardiovascular Diseases,2020,(2):571.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.003]
[2]韩敏 朱兵 余嘉清 马依彤.程序性细胞死亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
HAN MinZHU BingYU JiaqingMA Yitong. Programmed Cell Death and Myocardial Ischemic Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(2):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
[3]郭双 邢栋 吕勃.程序性坏死、细胞焦亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(12):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
GUO Shuang,XING Dong,LYU Bo.NecroptosisPyroptosis and Myocardial Ischemia-reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(2):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
[4]邢云 邓伟 唐其柱.Toll样受体与心血管疾病关系的研究进展[J].心血管病学进展,2021,(8):711.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.010]
XING Yun,DENG Wei,TANG Qizhu.Research Progress on the Role of Toll-Like Receptor in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2021,(2):711.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.010]
[5]彭石 马茜钰 张丹 张兆元 张锦.铁死亡在心肌缺血再灌注损伤中的作用及靶向治疗研究进展[J].心血管病学进展,2022,(4):357.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.017]
PENG Shi,MA Qianyu,ZHANG Dan,et al.Role and Targeted Treatment of Ferroptosis?n Myocardial Ischemia Reperfusion Injury[J].Advances in Cardiovascular Diseases,2022,(2):357.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.017]
[6]郭双 吕勃.细胞凋亡和程序性坏死在心肌缺血再灌注损伤中的作用研究[J].心血管病学进展,2022,(12):1148.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.020]
GUO Shuang L YU Bo.The Role of Apoptosis and Necroptosis in Myocardial Ischemia-Reperfusion Injury[J].Advances in Cardiovascular Diseases,2022,(2):1148.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.020]
[7]叶宇恒 钱玲玲 王如兴 李库林.心肌缺血再灌注损伤中铁死亡的调控机制研究进展[J].心血管病学进展,2023,(5):416.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.008]
YE Yuheng,QIAN Lingling,WANG Ruxing,et al.Regulatory Mechanisms of Ferroptosis in Myocardial Ischemia Reperfusion Injury[J].Advances in Cardiovascular Diseases,2023,(2):416.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.008]
[8]李秋 李蔚华.TRIM蛋白家族在心肌缺血再灌注损伤中的研究进展[J].心血管病学进展,2023,(8):743.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.016]
LI Qiu,LI Weihua.Research Progress of TRIM Family in Myocardial Ischemia Reperfusion Injury[J].Advances in Cardiovascular Diseases,2023,(2):743.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.016]
[9]李俊霖 韩虎魁 程攀科 李刚 陶剑虹.Foxp3+调节性T细胞与心肌缺血再灌注损伤概述[J].心血管病学进展,2023,(9):832.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.015]
LI Junlin,HAN Hukui,CHENG Panke,et al.Overview of Foxp3+ Regulatory T Cells and Myocardial Ischemia R eperfusion Injury[J].Advances in Cardiovascular Diseases,2023,(2):832.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.015]
[10]冉黔松 周厚荣.长链非编码RNA调节自噬在心肌缺血再灌注损伤中的研究进展[J].心血管病学进展,2024,(3):238.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.011]
RAN Qiansong ZHOU Hourong.Long Non-Coding RNA Regulating Autophagy in Myocardial Ischemia-Reperfusion Injury[J].Advances in Cardiovascular Diseases,2024,(2):238.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.011]